|
|
Retrospective analysis of 456 severe adverse drug reactions in our hospital |
SU Jin YI Wen-yan WANG Shi-yu |
Department of Pharmacy,Hezhou People′s Hospital,Guangxi Zhuang Autonomous Region,Hezhou 542800,China |
|
|
Abstract Objective To analyze the characteristics of severe adverse drug reactions(ADR)in our hospital,to provide a reference for rational and safe drug use in clinic,and to reduce the incidence of drug-induced diseases.Methods A total of 456 severe ADR reports from January 2014 to December 2018 in our hospital were collected,and analysis was performed from the patients′ age,gender,affected organs,drug types,route of administration,and outcomes.Results The proportion of male and female patients with severe ADR was almost same as 1.05∶1.Most of the patients were over 49 years old(>49 years old)accounting for 59.6%,and most of them occurred within 7 days of medication.The most frequently reported types of drugs were anti-tumor drugs,anti-tuberculosis drugs,and antibacterial drugs,accounting for 59.98%,14.58% and 13.11% respectively.The severe ADR occured most in combined use of drugs.The main route of administration was intravenous infusion,and the clinical manifestations were more common in blood system damage,hepatobiliary system and endocrine system damage.Conclusion The ADR monitoring of anti-tumor drugs,anti-tuberculosis drugs and antibacterial drugs should be paid great attention.Medication monitoring should be strengthened,and preventive measures should be taken to ensure the drug safety.
|
|
|
|
|
[1] |
The World Health Organization(2002)Safety of Medicines:A Guide to Detecting and Reporting Adverse Drug Reactions,Geneva.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC 4420988/.
|
[2] |
王敏.医疗机构药品不良反应监测现状与对策研究[J].药学服务与研究,2016,16(5):359-362.
|
[3] |
卫生部合理用药专家委员会.中国医师药师临床用药指南[M].2 版.重庆:重庆出版社,2014:1-36.
|
[4] |
国家药品不良反应中心,国家食品药品监督管理局药品评价中心.WHO 药品不良反应术语集[M].北京:中国医药科技出版社,2002:1-172.
|
[5] |
卫晓晓,高科江,吴萍,等.473 例新的和严重的药品不良反应分析[J].中国药师,2019,22(2):298-301.
|
[6] |
李旭,于军.老年人合理用药分析[J].中国老年学杂志,2019,39(7):1789-1791.
|
[7] |
倪佳,邵晓丽,李丽婷.2014~2016年某三甲医院严重药品不良反应分析[J].医药导报,2018,37(S1):135-137.
|
[8] |
陈思颖,尤海生,朱亚宁,等.134 例严重药品不良反应/事件报告分析[J].药物流行病学杂志,2016,25(9):559-562.
|
[9] |
朱磊,黄萍,李颖.519 例严重药品不良反应病例分析[J].中国医院药学杂志,2015,35(2):147-152.
|
[10] |
丁月霞,李硕硕,周芙蓉,等.基于烟台市药品不良反应数据库对严重药品不良反应的分析与评价[J].中国当代医药,2019,26(13):193-197.
|
[11] |
崔琪,闫素英.抗肿瘤药物引起的严重不良反应报告分析[J].中国临床药理学杂志,2015,31(8):654-656.
|
[12] |
寇炜,郭代红,田小燕,等.抗肿瘤药致不良反应15 183 例分析[J].中国药房,2018,29(4):508-511.
|
[13] |
任志强,刘英.121 例严重的药品不良反应报告分析[J].中国医院药学杂志,2015,35(14):1314-1317.
|
[14] |
郭雪玲,汤松,张万智,等.孝感市1463 例新的/严重的药品不良反应报告回顾性分析[J].药品流行病学杂志,2016,25(12):782-790.
|
[15] |
张俊忠.86 例严重药品不良反应分析[J].药学服务与研究,2018,18(6):475-478.
|
|
|
|